Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)

SHA:688192 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	34,401	17,237	19,530	16,030	14,959	-
Market Cap Growth	79.41%	-11.74%	21.83%	7.16%	-	-
Enterprise Value	33,333	17,342	18,891	14,518	14,805	-
Last Close Price	74.88	41.47	47.85	39.37	37.01	-
PS Ratio	67.27	47.89	213.94	-	1454.37	-
PB Ratio	21.12	86.16	23.01	9.12	6.07	-
P/TBV Ratio	28.40	-	50.51	12.66	7.53	-
EV/Sales Ratio	65.19	48.18	206.94	-	1439.37	-
Debt / Equity Ratio	0.72	5.79	0.48	0.05	0.04	-
Asset Turnover	0.21	0.22	0.05	-	0.01	0.03
Inventory Turnover	0.62	0.35	0.54	-	-	-
Quick Ratio	2.63	1.11	1.78	5.70	9.82	5.88
Current Ratio	2.71	1.27	2.03	5.93	9.96	6.06
Return on Equity (ROE)	-78.78%	-179.21%	-84.98%	-34.87%	-37.83%	-76.72%
Return on Assets (ROA)	-24.27%	-37.70%	-40.35%	-20.52%	-21.46%	-52.76%
Return on Capital (ROIC)	-28.68%	-46.33%	-46.54%	-22.54%	-23.23%	-62.42%
Earnings Yield	-2.55%	-4.91%	-5.67%	-4.59%	-4.48%	-
FCF Yield	-2.42%	-4.57%	-5.12%	-4.22%	-3.35%	-
Buyback Yield / Dilution	-3.17%	-1.83%	-0.70%	-12.29%	-0.07%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.